Study on metabolic syndrome
July 19, 2012
Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease
Authors: Paul-Labrador, M., Polk, D., Dwyer, J.H., Velasquez, I., Nidich, S., Rainforth, M., Schneider, R., Merz, C.N.
Published: Archives of Internal Medicine. 2006 Jun 12; vol 166(11): pp 1218-24.
Background: The metabolic syndrome is thought to be a contributor to coronary heart disease (CHD), and components of the syndrome have been identified as possible therapeutic targets. Previous data implicate neurohumoral activation related to psychosocial stress as a contributor to the metabolic syndrome. The aim of this study was to evaluate the efficacy of Transcendental Meditation (TM) on components of the metabolic syndrome and coronary heart disease.
Methods: We conducted a randomized, placebo-controlled clinical trial of 16 weeks of Transcendental Meditation or active control treatment (health education), matched for frequency and time, at an academic medical center in a total of 103 subjects with stablecoronary heart disease. Main outcome measures included blood pressure, lipoprotein profile, and insulin resistance determined by homeostasis model assessment (calculated as follows: [(fasting plasma glucose level [in milligrams per deciliter] x fasting plasma insulin level [in microunits per milliliter]) x 0.0552]/22.5); endothelial function measured by brachial artery reactivity testing; and cardiac autonomic system activity measured by heart rate variability.
Results: The Transcendental Meditation group had beneficial changes (measured as mean +/- SD) in adjusted systolic blood pressure (-3.4 +/- 2.0 vs 2.8 +/- 2.1 mm Hg; P = .04), insulin resistance (-0.75 +/- 2.04 vs 0.52 +/- 2.84; P = .01), and heart rate variability (0.10 +/- 0.17 vs -0.50 +/- 0.17 high-frequency power; P = .07) compared with the health education group, respectively. There was no effect of brachial artery reactivity testing.
Conclusions: Use of Transcendental Meditation for 16 weeks in coronary heart disease patients improved blood pressure and insulin resistance components of the metabolic syndrome as well as cardiac autonomic nervous system tone compared with a control group receiving health education. These results suggest that Transcendental Meditation may modulate the physiological response to stress and improve CHD risk factors, which may be a novel therapeutic target for the treatment of coronary heart disease.
See full article
Article access courtesy to Archives of Internal Medicine
See other recent scientific research articles on Transcendental Meditation!